Business
Endonovo Therapeutics Announces New Website Launch
Endonovo Therapeutics Announces New Website Launch.
About this update from Endonovo Therapeutics, Inc.
[{"type":"text","content":"\nThe completely redesigned website offers visitors deeper insight into the Company's core product, SofPulse®\n LOS ANGELES, CA, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) (\"Endonovo\" or the \"Company\"), a commercial-stage developer of non-invasive Electroceutical™ therapeutic devices, announced today the launch of its newly revamped website www.sofpulse.com. The website’s redesign has significantly improved functionality and enriched content focused on SofPulse®, Endonovo’s flagship product. SoftPulse® is an easy-to-place, non-invasive device that delivering targeted Pulsed Elctromagnetic Frequencies (tPEMF) to enhance post-surgical recovery, naturally. This innovative process utilizes proprietary technology to reduce pain, swelling and inflammation. The therapy is non-invasive and non-pharmacologic, with no known side effects and no potential for overdose or dependency. SofPulse® has been used effectively and studied extensively in soft tissue postoperative management. In addition to the upgraded SofPulse.com web site, Endonovo Therapeutics is proud to announce the release of our brand new 90 second “SofPulse® Solution” video. This short video provides viewers an up close and personal look at what SofPulse® is, what it does, how it works and how it provides groundbreaking benefits to patients and Physician’s alike. The video can be viewed on the home page. \"We are excited about our new website launch and the robust information it provides for patients, clinicians, medical community, partners and media to better understand SofPulse®,\" said Alan Collier, Endonovo’s Chief Executive Officer. “Our newly designed site will allow our visitors to have a thoroughly informative experience and introduces the SofPulse® Solution via our 90 second video. About Endonovo Therapeutics Endonovo Therapeutics, Inc. is a commercial-stage developer of non-invasive wearable Electroceuticals™ therapeutic devices. The Company's current portfolio of commercial and clinical-stage wearable Electroceuticals™ therapeutic devices addresses wound healing, pain, post-surgical pain and edema, cardiovascular disease, chronic kidney disease, and Central Nervous System (CNS) Disorders, including traumatic brain injury...